J

Jiangsu Cowin Biotech Co Ltd
SSE:688426

Watchlist Manager
Jiangsu Cowin Biotech Co Ltd
SSE:688426
Watchlist
Price: 27.77 CNY -0.39% Market Closed
Market Cap: ¥3.1B

Wall Street
Price Targets

Price Targets Summary
Jiangsu Cowin Biotech Co Ltd

There are no price targets for Jiangsu Cowin Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Jiangsu Cowin Biotech Co Ltd Competitors:
Price Targets
SANA
Sana Biotechnology Inc
67% Upside
STG
Strip Tinning Holdings PLC
122% Upside
NN
NextNav Inc
18% Upside
QXO
SilverSun Technologies Inc
37% Upside

Revenue
Forecast

-14% / Year
Past Growth
127% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-14% / Year
Past Growth
127% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 4 years the compound annual growth rate for Jiangsu Cowin Biotech Co Ltd's revenue is -14%. The projected CAGR for the next 2 years is 127%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Jiangsu Cowin Biotech Co Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jiangsu Cowin Biotech Co Ltd's stock price target?
Not Available

Jiangsu Cowin Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Jiangsu Cowin Biotech Co Ltd's Revenue forecast?
Projected CAGR
127%

For the last 4 years the compound annual growth rate for Jiangsu Cowin Biotech Co Ltd's revenue is -14%. The projected CAGR for the next 2 years is 127%.

Back to Top